Comparison of two self-assembled macromolecular prodrug micelles with different conjugate positions of SN38 for enhancing antitumor activity

References

• UlukanHSwaanPWCamptothecins: a review of their chemotherapeutic potentialDrugs200262142039205712269849
   PubMed Web of Science ®Google Scholar
• ZhangYZhangHWuWFolate-targeted paclitaxel-conjugated polymeric micelles inhibits pulmonary metastatic hepatoma in experimental murine H22 metastasis modelsInt J Nanomedicine201492019203024790440
   PubMed Web of Science ®Google Scholar
• KawatoYAonumaMHirotaYKugaHSatoKIntracellular roles of SN38, a metabolite of the camptothecin derivative CPT-11, in the antitumor effect of CPT-11Cancer Res19915116418741911651156
   PubMed Web of Science ®Google Scholar
• PommierYTopoisomerase I inhibitors: camptothecins and beyondNat Rev Cancer200661078980216990856
   PubMed Web of Science ®Google Scholar
• RogerELagarceFBenoitJPDevelopment and characterization of a novel lipid nanocapsule formulation of Sn38 for oral administrationEur J Pharm Biopharm201179118118821303693
   PubMed Web of Science ®Google Scholar
• GuptaELestingiTMMickRRamirezJVokesEERatainMJMetabolic fate of irinotecan in humans: correlation of glucuronidation with diarrheaCancer Res19945414372337258033091
   PubMed Web of Science ®Google Scholar
• MathijssenRHvan AlphenRJVerweijJClinical pharmacokinetics and metabolism of irinotecan (CPT-11)Clin Cancer Res2001782182219411489791
   PubMed Web of Science ®Google Scholar
• HoffDVFuture directions of clinical research with CPT-11 (irinotecan)Eur J Cancer199632Suppl 3S9S12
   Google Scholar
• ChabotGGClinical pharmacokinetics of irinotecanClin Pharmacokinet19973342452599342501
   PubMed Web of Science ®Google Scholar
• PeikovVUgwuSParmarMZhangAAhmadIpH-dependent association of SN-38 with lipid bilayers of a novel liposomal formulationInt J Pharm20052991–2929915996839
   PubMed Web of Science ®Google Scholar
• ZhangJAXuanTParmarMDevelopment and characterization of a novel liposome-based formulation of SN-38Int J Pharm20042701–29310714726126
   PubMed Web of Science ®Google Scholar
• ChenMLiuYYangWPreparation and characterization of self-assembled nanoparticles of 6-O-cholesterol-modified chitosan for drug deliveryCarbohydr Polym201184412441251
   Web of Science ®Google Scholar
• DuanKZhangXTangXFabrication of cationic nanomicelle from chitosan-graft-polycaprolactone as the carrier of 7-ethyl-10-hydroxy-camptothecinColloids Surf B Biointerfaces201076247548220047821
   PubMed Web of Science ®Google Scholar
• EbrahimnejadPDinarvandRSajadiSAAtyabiFRamezaniFJaafariMRPreparation and characterization of poly lactide-co-glycolide nanoparticles of SN-38PDA J Pharm Sci Technol200963651252020169857
   PubMedGoogle Scholar
• SepehriNRouhaniHTavassolianFSN38 polymeric nanoparticles: in vitro cytotoxicity and in vivo antitumor efficacy in xenograft babl/c model with breast cancer versus irinotecanInt J Pharm20144711–248549724879937
   PubMedGoogle Scholar
• VangaraKKLiuJPalakurthiSHyaluronic acid-decorated PLGA-PEG nanoparticles for targeted delivery of SN-38 to ovarian cancerAnticancer Res20133362425243423749891
   PubMed Web of Science ®Google Scholar
• ManasponCNittayacharnPVejjasilpaKFongsukCNasongklaNSN-38: β-cyclodextrin inclusion complex for in situ solidifying injectable polymer implantsConf Proc IEEE Eng Med Biol Soc201120113241324422255030
   PubMedGoogle Scholar
• VijayalakshmiNRayAMaluginAGhandehariHCarboxyl-terminated PAMAM-SN38 conjugates: synthesis, characterization, and in vitro evaluationBioconjug Chem201021101804181020836544
   PubMed Web of Science ®Google Scholar
• KoizumiFKitagawaMNegishiTNovel SN-38-incorporating polymeric micelles, NK012, eradicate vascular endothelial growth factor-secreting bulky tumorsCancer Res20066620100481005617047068
   PubMed Web of Science ®Google Scholar
• SaitoYYasunagaMKurodaJKogaYMatsumuraYAntitumour activity of NK012, SN-38-incorporating polymeric micelles, in hypovascular orthotopic pancreatic tumourEur J Cancer201046365065820015633
   PubMed Web of Science ®Google Scholar
• DamanZOstadSAminiMGilaniKPreparation, optimization and in vitro characterization of stearoyl-gemcitabine polymeric micelles: a comparison with its self-assembled nanoparticlesInt J Pharm20144681–214215124731731
   PubMedGoogle Scholar
• HuangLSongJChenBA novel targeting drug carrier to deliver chemical bonded and physical entrapped anti-tumor drugsInt J Pharm20144661–2525724607212
   PubMedGoogle Scholar
• MaoLWangHTanMQuLKongDYangZConjugation of two complementary anti-cancer drugs confers molecular hydrogels as a co-delivery systemChem Commun (Camb)201248339539722080052
   PubMed Web of Science ®Google Scholar
• GreenwaldRBPendriAConoverCGilbertCYangRXiaJDrug delivery systems. 2. Camptothecin 20-O-poly(ethylene glycol) ester transport formsJ Med Chem19963910193819408642549
   PubMed Web of Science ®Google Scholar
• WaniMCNicholasAWManikumarGWallMEPlant antitumor agents. 25. Total synthesis and antileukemic activity of ring A rubstituted camptothecin analogues. Structure-activity correlationsJ Med Chem19873010177417793656353
   PubMed Web of Science ®Google Scholar
• WangCYPanXDLiuHYFuZDWeiXYYangLXSynthesis and antitumor activity of 20-O-linked succinate-based camptothecin ester derivativesBioorg Med Chem200412133657366215186850
   PubMed Web of Science ®Google Scholar
• LeeKYHaWSParkWHBlood compatibility and biodegradability of partially N-acylated chitosan derivativesBiomaterials19951616121112168589189
   PubMed Web of Science ®Google Scholar
• HiranoSSeinoHAkiyamaYNonakaIChitosan: a biocompatible material for oral and intravenous administrationsGebeleinCGDunnRLProgress in Biomedical PolymersNew York, NYPlenum Publishing Co1990283290
   Google Scholar
• DuhemNRollandJRivaRTocol modified glycol chitosan for the oral delivery of poorly soluble drugsInt J Pharm2012423245246022212463
   PubMedGoogle Scholar
• WangXYZhangLWeiXHWangQMolecular dynamics of paclitaxel encapsulated by salicylic acid-grafted chitosan oligosaccharide aggregatesBiomaterials20133471843185123219327
   PubMed Web of Science ®Google Scholar
• ZhangCQinengPZhangHSelf-assembly and characterization of paclitaxel-loaded N-octyl-O-sulfate chitosan micellar systemColloids Surf B Biointerfaces2004391–2697515542343
   PubMed Web of Science ®Google Scholar
• ZhangJChenXGLiYYLiuCSSelf-assembled nanoparticles based on hydrophobically modified chitosan as carriers for doxorubicinNanomedicine20073425826517962086
   PubMed Web of Science ®Google Scholar
• MoonSJGovindanSVCardilloTMD’SouzaCAHansenHJGoldenbergDMAntibody conjugates of 7-ethyl-10-hydroxycamptothecin (SN-38) for targeted cancer chemotherapyJ Med Chem200851216916692618939816
   PubMed Web of Science ®Google Scholar
• JonSLeeELeeJJLeeIinventorGwangju Institute of Science and Technology, assigneeTransmucosal delivery of pharmaceutical active substancesUnited States patent US2007029238720071220
   Google Scholar
• AngenaultSThirotSSchmidtFMonneretCPfeifferBRenardPCancer chemotherapy: a SN-38 (7-ethyl-10-hydroxycamptothecin) glucuronide prodrug for treatment by a PMT (prodrug monotherapy) strategyBioorg Med Chem Lett200313594795012617927
   PubMed Web of Science ®Google Scholar
• ZhangHWangJMaoWNovel SN38 conjugate-forming nanoparticles as anticancer prodrug: in vitro and in vivo studiesJ Control Release2013166214715823266448
   PubMed Web of Science ®Google Scholar
• HuQLiangBSunYPreparation of bufalin-loaded pluronic polyetherimide nanoparticles, cellular uptake, distribution, and effect on colorectal cancerInt J Nanomedicine201494035404125187707
   PubMed Web of Science ®Google Scholar
• KawatoYFurutaTAonumaMYasuokaMYokokuraTMatsumotoKAntitumor activity of a camptothecin derivative, CPT-11, against human tumor xenografts in nude miceCancer Chemother Pharmacol19912831921981855276
   PubMed Web of Science ®Google Scholar
• GuoMRongWTHouJMechanisms of chitosan-coated poly(lactic-co-glycolic acid) nanoparticles for improving oral absorption of 7-ethyl-10-hydroxycamptothecinNanotechnology2013242424510123702815
   PubMed Web of Science ®Google Scholar
• WangJSunJChenQStar-shape copolymer of lysine-linked di-tocopherol polyethylene glycol 2000 succinate for doxorubicin delivery with reversal of multidrug resistanceBiomaterials201233286877688822770799
   PubMed Web of Science ®Google Scholar
• HeXLuWJiangXCaiJZhangXDingJSynthesis and biological evaluation of bis and monocarbonate prodrugs of 10-hydroxycamptothecinsBioorg Med Chem200412154003400815246077
   PubMed Web of Science ®Google Scholar
• BurkeTGMiZPreferential binding of carboxylate form of camptothecin by human serum albuminAnal Biochem199321212852878368506
   PubMed Web of Science ®Google Scholar
• RahierNJEisenhauerBMGaoRJonesSHHechtSMWater-soluble camptothecin derivatives that are intrinsic topoisomerase I poisonsOrg Lett20046332132414748583
   PubMed Web of Science ®Google Scholar